During the past decade, ICH Study Center GmbH & Co. KG conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 12 clinical trials were completed, i.e. on average, 109.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICH Study Center GmbH & Co. KG" #1 sponsor was "Gilead Sciences" with 13 trials, followed by "Janssen Sciences Ireland UC" with 2 trials sponsored, "NEAT ID Foundation" with 2 trials sponsored, "Heidelberg ImmunoTherapeutics GmbH" with 1 trials sponsored and "MUC Research GmbH" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICH Study Center GmbH & Co. KG" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "ICH Study Center GmbH & Co. KG" are "HIV Infections" (6 trials), "HIV-1 Infection" (6 trials), "HIV" (4 trials), "HIV-1-infection" (3 trials) and "Acquired Immunodeficiency Syndrome" (2 trials). Many other conditions were trialed in "ICH Study Center GmbH & Co. KG" in a lesser frequency.

Most popular intervention types in "ICH Study Center GmbH & Co. KG" are "Drug" (20 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "FTC/TDF" (5 trials), "RTV" (4 trials), "ATV" (3 trials), "EFV/FTC/TDF" (3 trials) and "FTC/RPV/TDF" (3 trials). Other intervention names were less common.

The vast majority of trials in "ICH Study Center GmbH & Co. KG" are 23 trials for "All" genders.

Currently, there are NaN active trials in "ICH Study Center GmbH & Co. KG". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in ICH Study Center GmbH & Co. KG, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ICH Study Center GmbH & Co. KG, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".